HM Payson & Co’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.49K | Hold |
100
| – | – | ﹤0.01% | 979 |
|
|
2024
Q4 | $1.32K | Hold |
100
| – | – | ﹤0.01% | 988 |
|
|
2024
Q3 | $1.42K | Hold |
100
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q2 | $1.29K | Hold |
100
| – | – | ﹤0.01% | 943 |
|
|
2024
Q1 | $1.39K | Sell |
100
-186
| -65% | -$2.58K | ﹤0.01% | 916 |
|
|
2023
Q4 | $4.08K | Sell |
286
-503
| -64% | -$7.18K | ﹤0.01% | 877 |
|
|
2023
Q3 | $12.2K | Buy |
789
+503
| +176% | +$7.78K | ﹤0.01% | 797 |
|
|
2023
Q2 | $4.49K | Hold |
286
| – | – | ﹤0.01% | 860 |
|
|
2023
Q1 | $4.71K | Sell |
286
-105
| -27% | -$1.73K | ﹤0.01% | 861 |
|
|
2022
Q4 | $6.1K | Buy |
391
+105
| +37% | +$1.64K | ﹤0.01% | 787 |
|
|
2022
Q3 | $4K | Hold |
286
| – | – | ﹤0.01% | 871 |
|
|
2022
Q2 | $4K | Hold |
286
| – | – | ﹤0.01% | 915 |
|
|
2022
Q1 | $4K | Sell |
286
-745
| -72% | -$10.4K | ﹤0.01% | 931 |
|
|
2021
Q4 | $14K | Hold |
1,031
| – | – | ﹤0.01% | 824 |
|
|
2021
Q3 | $17K | Hold |
1,031
| – | – | ﹤0.01% | 768 |
|
|
2021
Q2 | $17K | Sell |
1,031
-10
| -1% | -$165 | ﹤0.01% | 773 |
|
|
2021
Q1 | $19K | Hold |
1,041
| – | – | ﹤0.01% | 769 |
|
|
2020
Q4 | $19K | Hold |
1,041
| – | – | ﹤0.01% | 780 |
|
|
2020
Q3 | $19K | Hold |
1,041
| – | – | ﹤0.01% | 741 |
|
|
2020
Q2 | $19K | Hold |
1,041
| – | – | ﹤0.01% | 678 |
|
|
2020
Q1 | $16K | Sell |
1,041
-251
| -19% | -$3.86K | ﹤0.01% | 683 |
|
|
2019
Q4 | $25K | Sell |
1,292
-1,981
| -61% | -$38.3K | ﹤0.01% | 692 |
|
|
2019
Q3 | $56K | Sell |
3,273
-1,236
| -27% | -$21.1K | ﹤0.01% | 573 |
|
|
2019
Q2 | $80K | Buy |
+4,509
| New | +$80K | ﹤0.01% | 521 |
|